Obesity drug sales help Novo Nordisk beat expectations
Sales of Novo Nordisk’s obesity drug, Wegovy, rose by more than 50 per cent last year, helping the Danish drugmaker beat revenue expectations. The company on Wednesday reported that net sales increased by 26 per cent year on year in 2024 to DKr290bn ($40bn),
The widow of a 48-year-old man who died after weight loss surgery is taking legal action against the private healthcare firm ...
Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...
EGOT winner Whoopi Goldberg railed against an ad that's circulating on social media with a manipulated version of her ...
While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...
New research uncovers hidden risks and surprising benefits of weight loss drugs like Ozempic, reshaping how we see these ...
Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...
Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...
When Jeanne began to seriously consider taking Zepbound, one of the new-generation weight-loss drugs, she had the briefest of ...
The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...
Study researcher Dr. Akira Takahashi, head of medicine at Tesseikai Neurosurgical Hospital in Osaka, Japan, conducted the ...
MUI FITNESS US (English) on MSN21h
These Are the 8 Best Drinks to Curb Cravings and Lose Weight!Tired of battling cravings that sabotage your weight loss efforts? Worry no more! Discover in this article the 8 most ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback